Heck, a lot of people are starting to post stuff a lot like I would. This is great! Saves me a lot of time. I used to have to go out and find all my ideas by sorting through thousands of pink sheeters and OTC companies. having a central access point of likeminded investors stating their opinion on stuff that i already like is doing what I thought it would. I figured a year ago, we would go through waves of new investors coming to this sector and we are and have. We are starting to garner large institutional attention, but we still aren’t even close to where things will start turning south. Lots of getting something for nothing. Hop in, but only if you know what you’re doing. If you don’t you’re bound to get taken for stuff. I do my best not to discuss bad opportunities for any duration… they just aren’t worth my time or yours. Note that my priority goes to my investors first. Thus, I don’t always cover the best opportunities anymore as I find them… as I’m usually buying them.
CCME – what else is there left to be said about this one
CNYD – “synergy”
LPIH – imminent uplisting
LTUS – 2 times cash, much more growth to come
CKGT – 2010 PE 4ish, cigs could be big
CHBT – mountain of cash, huge growth coming
SOKF – wonderful business
BFAR – 2010 PE 2, solid growth
ENHD – 2010 PE<3, more profitable than HOGS, nice cash flow
CHNC - 2010 PE 3, just tripled capacity, historic 30% growth rate
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=48558972
CCLWF – leverage, leverage, leverage; good business with a warrant that doesn’t expire until 11/12 but will provide a 400% return if the share price appreciates a bit over 50%, for nearly 8x leverage.
CCME – nothing to add, love the moat and cash to expand; already uplisted, so sooner to get noticed
NEP – great cash flow and customer relationships; one of the safest plays with still good upside potential. Should be a $15-$20 IMO at minimum. Already uplisted.
CHOP – great leverage again through warrants; already uplisted; once it gets past warrant overhang, should take off
SOKF – hard to find anything wrong with them; good growth, good valuation, excellent cash flow
CNYD – good moat, cash flow, growth plans
LIWA – Strong business & growth plans; good valuation; ok cash flow
CKGT – Steady, unlikely to dissappoint
BSPM – Looking for continued expansion, would like to see another drug of significance added to network.
CSGH – Speculative play and potential homerun, but good valuation without the homerun, so should be limited downside. Overall, I usually avoid technology plays because of rate of change, but intrigued by this one.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=48563487
[ad#Google Adsense]
I’ve done some musings lately.
http://www.glenbradford.com/files/Stocks/Best%20investors.pdf
http://www.glenbradford.com/files/Stocks/fooled%20by%20randomness%20notes.pdf